Changes of activity of prostate acid phosphatase in serum and prostatic tissue in rat 4 months after vasectomy 输精管结扎4月大鼠血清与前列腺组织的前列腺酸性磷酸酶(PAP)活力变化
AIM : To study molecular mechanism of epristeride in the treatment of benign prostatic hyperplasia and discuss the possibility of using prostate acid phosphatase ( AGP ) as a marker of the atrophy of prostatic gland in vivo. 目的:研究爱普列特是否通过诱导前列腺细胞凋亡来治疗前列腺良性增生。探讨以前列腺酸性磷酸酶(PAP)作为前列腺萎缩标志的可行性。
There seems to be a strong association between CP and semen delayed liquefaction. Researches on the mechanism of semen delayed liquefaction resulting from CP mainly focus on the proteolytic ferment, plasminogen activator, prostate acid phosphatase, tissue factor, lack of zinc, and pH. 目前对CP所致精液延迟液化机制的研究主要集中在蛋白水解酶系、纤溶酶原激活因子系统和微量元素锌缺乏以及pH值改变等方面。
Differentiation of Prostatic Carcinoma and Benign Prostatic Hypertrophy by Determination of Prostate Specific Antigen and Prostatic Acid Phosphatase 前列腺特异抗原和酸性磷酸酶测定用于鉴别前列腺癌和前列腺肥大
Evaluation of the clinical usefulness of prostate specific antigen and prostatic acid phosphatase 前列腺特异性抗原和前列腺酸性磷酸酶(PAP)的临床应用价值比较